Erlizumab
Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Erlizumab
Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock.
has abstract
Erlizumab, also known as rhuMA ...... , stroke, and traumatic shock.
@en
L'erlizumab, noto anche come r ...... e boccando il recettore CD-18.
@it
إرليزوماب هو جسم مضاد وحيد الن ...... . أوقفت التجارب في يونيو 2000.
@ar
CAS number
211323-03-4
FDA UNII code
X77RS4CMJF
KEGG
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
984,355,652
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
KEGG
D04045
@en
mab type
F2
@en
source
zu/o
@en
target
type
mab
@en
UNII
X77RS4CMJF
@en
Verifiedfields
changed
@en
verifiedrevid
457,120,620
wikiPageUsesTemplate
hypernym
comment
Erlizumab, also known as rhuMA ...... , stroke, and traumatic shock.
@en
L'erlizumab, noto anche come r ...... e boccando il recettore CD-18.
@it
إرليزوماب هو جسم مضاد وحيد الن ...... . أوقفت التجارب في يونيو 2000.
@ar
label
Erlizumab
@en
Erlizumab
@it
إرليزوماب
@ar